wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q24658506-019280D0-1D0D-4FFE-9ECD-610D7ED2F177
Q24658506-019280D0-1D0D-4FFE-9ECD-610D7ED2F177
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24658506-019280D0-1D0D-4FFE-9ECD-610D7ED2F177
Efficacy and safety of the oral Janus kinase inhibitor peficitinib (ASP015K) monotherapy in patients with moderate to severe rheumatoid arthritis in Japan: a 12-week, randomised, double-blind, placebo-controlled phase IIb study
P2860
Q24658506-019280D0-1D0D-4FFE-9ECD-610D7ED2F177
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24658506-019280D0-1D0D-4FFE-9ECD-610D7ED2F177
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
64900ef6bae6c413cc4805700692a8e0eba3fa25
P2860
A phase 2a randomized, double-blind, placebo-controlled, sequential dose-escalation study to evaluate the efficacy and safety of ASP015K, a novel Janus kinase inhibitor, in patients with moderate-to-severe psoriasis.